NEVIRA nevirapine 200 mg tablets blister pack

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Osta kohe

Avaliku hindamisaruande Avaliku hindamisaruande (PAR)
28-11-2017

Toimeaine:

nevirapine, Quantity: 200 mg

Saadav alates:

Sun Pharma ANZ Pty Ltd

INN (Rahvusvaheline Nimetus):

Nevirapine

Ravimvorm:

Tablet, uncoated

Koostis:

Excipient Ingredients: colloidal anhydrous silica; lactose monohydrate; microcrystalline cellulose; magnesium stearate; povidone; sodium starch glycollate type A

Manustamisviis:

Oral

Ühikuid pakis:

14, 60, 100

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

Nevirapine in combination with antiretroviral agents is indicated for the treatment of HIV-1 infection in adults and adolescents over the age of 16 years.,Resistant virus emerges rapidly when Nevirapine is administered as monotherapy or in dual combination therapy with an antiretroviral agent. Therefore, nevirapine should always be administered in combination with at least two additional antiretroviral agents.

Toote kokkuvõte:

Visual Identification: White to off-white, oval-shaped, uncoated tablets with a break line on both sides and debossed with 'RX921' on one side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Volitamisolek:

Licence status A

Loa andmise kuupäev:

2012-11-07